VERU INC. Payments of Debt Issuance Costs
VERU INC. (VERU) reported Payments of Debt Issuance Costs of $266.92 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2019-12-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2019-12-12
- VERU INC. payments of debt issuance costs for the quarter ending 2018-09-30 was $0.00.
- VERU INC. payments of debt issuance costs for the quarter ending 2018-06-30 was $146.92K.
- VERU INC. payments of debt issuance costs for fiscal 2018 was $266.92K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $146.92K derived: sum of 2 quarters · filed 2019-12-12 | $266.92K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $146.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | $266.92K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $120.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |